• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Baseline Prognostic Factors and Statistic Model to Predict Early Virological Response in Lamivudine-

Baseline Prognostic Factors and Statistic Model to Predict Early Virological Response in Lamivudine-

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：haizibooks
【摘 要】
：
Background:Hepatitis B virus(HBV)infection is still a worldwide disease which may cause liver cirrhosis or even hepatocellular carcinoma.Lamivudine is a potent nucleoside analogue used in treating chr
【作 者】
：
Rui zhou Fan Pan 
【机 构】
：
Department of Institute of Infectious Diseases and Center of Liver Diseases,Infectious Disease Hospi
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Hepatitis B virus(HBV)infection is still a worldwide disease which may cause liver cirrhosis or even hepatocellular carcinoma.Lamivudine is a potent nucleoside analogue used in treating chronic hepatitis B(CHB).However,resistance to the drug remains a problem.As early virological response can predict longterm efficacy of nucleotide analogue treatment,we analyzed all lamivudine recipients in this trial to determine the baseline characteristics and a model to predict early virological response reflecting the long-term effect of lamivudine.
其他文献
Impaired function of CD4+T follicular helper(Tfh)cells associated with hepatocellular carcinoma prog
Background:CD4+T follicular helper(Tfh) cells,a new subset of immune cells,have been demonstrated to be involved in the development and prognosis of tumors.
会议
Assembly of Lipid-Polymer Hybrid Nanoparticles for Encapsulating a Non-nucleosidic Novel HBV Inhibit
Background:The advent of nanotechnology has provided a new and powerful tool in medical fields.Of all the application of nanotechnology,nanoparticle-delivery system attracted many attentions.As a deli
会议
Study of influence factors on HBV relapse after NAs withdrawl in the HBeAg positive CHB patients who
Background:Oobjective:To explore the influence factors on HBV relapse after Nucleos(t)ide analogues(NAs)withdrawal in the Hepatitis B e antigen positive chronic hepatitis B(CHB)patients who met NAs ce
会议
INVESTIGATION OF ETIOLOGY AND CLINICAL CHARACTERISTICS OF 573 PATIENTS SUFFERED FROM PRIMARY HEPATIC
Objective:To investigate etiology,risk factors and clinical characteristics of primary hepatic carcinoma(PHC)in Hebei province to better strategies for disease prevention,diagnosis and treatment.
会议
EFFECTS OF ORAL ANTI-VIRAL AGENTS ON LONG-TERM OUTCOMES OF TREATMENT NA(I)VE PATIENTS WITH HBVRELATE
Background:Data regarding the long term outcome of HBV-related decompensated cirrhosis is rare,especially following oral nucleos(t)ide analogues use in such patients.
会议
Magnesium isoglycyrrhizinate ameliorates alcohol-induced fatty liver by inhibiting endoplasmic retic
liver damage and is one of the major causes of fatty liver worldwide.Although many drugs have been reported to have protective effects against alcoholic liver disease(ALD),there is finite available tr
会议
Analysis of pre-existing drug resistance mutations might-related to tenofovir in patients with chron
Background:We amplified and analyzed the hepatitis B virus(HBV) reverse transcriptase(RT) sequences of 75 Chinese patients with chronic hepatitis B who have been treated with nucleos(t)ide analogues e
会议
The factors affecting HBeAg seroconversion of initial treatment with nucleoside analogue among HBeAg
Background:The aim of this study is to analysis the factors affecting HBeAg seroconversion of initial treatment using nucleoside analogue among HBeAgpositive patients.
会议
NFATC3 exerts anti-tumor and anti-viral dual function in hepatitis B virus-related hepatocellular ca
Background:The nuclear factor of activated T-cells,cytoplasmic 3(NFATC3)belongs to a family of transcription factors that can orchestrate an effective immune response mainly in T cells.But the functio
会议
A Model to Estimate Survival in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Patients Ba
Background:Acute-on-chronic liver failure(ACLF)caused by hepatitis B virus(HBV)is a severe disease with high mortality.We aimed to develop a survival model for HBV-related ACLF based on dynamic change
会议